Pharmaceuticals, Biotechnology and Life Sciences
Amryt has begun with “EASE”, the Phase 3 clinical trial of AP101, its lead drug candidate, which offers a potential treatment for a rare genetic skin disorder that causes fragile skin.
Inventiva, a biopharmaceutical company developing innovative therapies, particularly to treat fibrosis, has reported its financial results for the year ended December 31, 2016.
Bioventix, a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, has reported unaudited interim financial results for the six-month period ending 31 December 2016.
Amryt, the pharmaceutical company focused on treatments for rare and orphan diseases, has appointed David Allmond as Chief Commercial Officer in a non-board capacity, with effect from 3 April 2017.
MDxHealth has reported results from a castration resistant prostate cancer (CRPC) treatment study.
Erytech Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, has reported positive topline results from its Phase 2b clinical study evaluating its product candidate, eryaspase (GRASPA), in combination with chemotherapy for the treatment of second-line metastatic pancreatic cancer.
PureTech Health said on Friday that it will advance with Novartis two clinical-stage programmes targeting the mechanistic target of rapamycin complex 1 (mTORC1) pathway.
Three of Europe’s top drugmakers face critical verdicts from U.S. regulators next week, with Sanofi <SASY.PA> and Roche <ROG.S> likely to win approvals for two new products, while GlaxoSmithKline <GSK.L> braces for a potential generic rival.
Teva Pharmaceutical Industries <TEVA.TA> may fire as many as 6,000 workers worldwide as part of a multi-year efficiency plan, Israel’s Calcalist news website reported on Thursday.
Futura medical, healthcare company focused on advanced transdermal technology, has announced its preliminary results for the year 2016.